Prevalence of hepatitis C virus (HCV) antibodies in haemodialysis patients
The prevalence of antibodies to HCV and the course of hepatitis have been determined in 357 haemodialysed patients treated at a single institution.
The prevalence of HCV infection increases with the duration of haemodialysis and with the use of blood transfusions, yet there is high frequency of HCV seropositivity even without blood transfusions. Evolution of HCV hepatitis to chronicity is frequent and biological signs of chronic hepatopathy can coexist with absence of alanine aminotransferase (ALT) abnormalities.
KeywordsDialysis Unit Maintenance Dialysis Haemodialysed Patient Chronic Hepatopathy Dialysis Department
Unable to display preview. Download preview PDF.
- 1.Marchesi D, Arid C, Poletti E, Mingardi G, Minola E, Mecca G (1988) Outbreak of non-A, non-B hepatitis in center hemodialysis patients: A retrospective analysis. Nephrol Dial Transplant 3: 795–799Google Scholar
- 2.Hopf U, Möller B, Kiither D, Stemerowicz R, Lobeck H, Lüdtke-Handjery A, Walter E, Blum HE, Roggendorf M, Deinhardt F (1990) Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV). Hepatology 10: 69–76Google Scholar